Purple Biotech Ltd (TLV:PPBT)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.200
0.00 (0.00%)
At close: Jan 9, 2026
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of 22.3 million as of January 9, 2026. Its market cap has decreased by -41.66% in one year.
Market Cap
22.30M
Enterprise Value
-11.33M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.20
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from 17.87M to 22.30M, an increase of 24.77%. That is a compound annual growth rate of 1.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 22.30M | - |
| Dec 31, 2025 | 22.30M | -44.71% |
| Dec 31, 2024 | 40.34M | -48.30% |
| Dec 31, 2023 | 78.02M | -17.30% |
| Dec 29, 2022 | 94.35M | -55.64% |
| Dec 30, 2021 | 212.71M | -1.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 115.77B |
| Danel (Adir Yeoshua) | 2.91B |
| Kamada | 1.49B |
| BrainsWay | 1.46B |
| SofWave Medical | 1.18B |
| Bait Bakfar | 1.06B |
| Ilex Medical | 774.22M |
| Novolog (Pharm-Up 1966) | 664.14M |